Buspirone Hydrochloride

Product NDC: 75834-270
11-digit product format: 758340270
Labeler code: 75834
Product ID: 75834-270_5bad7053-8f63-45fc-adb0-88c628fa039b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Buspirone Hydrochloride
Dosage form: TABLET
Route: ORAL
Labeler: Nivagen Pharmaceuticals Inc.
Application: ANDA209696
Marketing category: ANDA
Marketing start: 2021-02-15
Substance: BUSPIRONE HYDROCHLORIDE
Active strength: 30 mg/1
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A209696-001	BUSPIRONE HYDROCHLORIDE	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	BX	2018-05-03
A209696-002	BUSPIRONE HYDROCHLORIDE	BUSPIRONE HYDROCHLORIDE	7.5MG	TABLET / ORAL	BX	2018-05-03
A209696-003	BUSPIRONE HYDROCHLORIDE	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	BX	2018-05-03
A209696-004	BUSPIRONE HYDROCHLORIDE	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	BX	2018-05-03
A209696-005	BUSPIRONE HYDROCHLORIDE	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	BX	2018-05-03

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 5 matching rows.

Application-product, TE code table
Application-product	TE code
A209696-001	BX
A209696-002	BX
A209696-003	BX
A209696-004	BX
A209696-005	BX

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 6 · 205 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A209696-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	BX	2018-05-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209696-002	BUSPIRONE HYDROCHLORIDE	7.5MG	TABLET / ORAL	BX	2018-05-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209696-003	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	BX	2018-05-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209696-004	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	BX	2018-05-03	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209696-005	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	BX	2018-05-03	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209696-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	BX	2018-05-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209696-002	BUSPIRONE HYDROCHLORIDE	7.5MG	TABLET / ORAL	BX	2018-05-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209696-003	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	BX	2018-05-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209696-004	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	BX	2018-05-03	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209696-005	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	BX	2018-05-03	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209696-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	BX	2018-05-03	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209696-002	BUSPIRONE HYDROCHLORIDE	7.5MG	TABLET / ORAL	BX	2018-05-03	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209696-003	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	BX	2018-05-03	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209696-004	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	BX	2018-05-03	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209696-005	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	BX	2018-05-03	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209696-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB	2018-05-03	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209696-002	BUSPIRONE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB	2018-05-03	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209696-003	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	2018-05-03	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209696-004	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB	2018-05-03	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209696-005	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB	2018-05-03	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209696-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB	2018-05-03	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209696-002	BUSPIRONE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB	2018-05-03	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209696-003	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	2018-05-03	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209696-004	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB	2018-05-03	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209696-005	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB	2018-05-03	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209696-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB	2018-05-03	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209696-002	BUSPIRONE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB	2018-05-03	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209696-003	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	2018-05-03	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209696-004	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB	2018-05-03	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209696-005	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB	2018-05-03	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209696-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB	2018-05-03	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209696-002	BUSPIRONE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB	2018-05-03	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209696-003	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	2018-05-03	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209696-004	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB	2018-05-03	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209696-005	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB	2018-05-03	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209696-001	BUSPIRONE HYDROCHLORIDE	5MG	TABLET / ORAL	AB	2018-05-03	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209696-002	BUSPIRONE HYDROCHLORIDE	7.5MG	TABLET / ORAL	AB	2018-05-03	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209696-003	BUSPIRONE HYDROCHLORIDE	10MG	TABLET / ORAL	AB	2018-05-03	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209696-004	BUSPIRONE HYDROCHLORIDE	15MG	TABLET / ORAL	AB	2018-05-03	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209696-005	BUSPIRONE HYDROCHLORIDE	30MG	TABLET / ORAL	AB	2018-05-03	`5bbf6a4d5a75…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 6 · 205 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A209696-001	BX	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209696-002	BX	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209696-003	BX	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209696-004	BX	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209696-005	BX	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209696-001	BX	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209696-002	BX	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209696-003	BX	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209696-004	BX	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209696-005	BX	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209696-001	BX	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209696-002	BX	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209696-003	BX	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209696-004	BX	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209696-005	BX	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209696-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209696-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209696-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209696-004	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209696-005	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209696-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209696-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209696-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209696-004	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209696-005	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209696-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209696-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209696-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209696-004	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209696-005	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209696-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209696-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209696-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209696-004	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209696-005	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209696-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209696-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209696-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209696-004	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209696-005	AB	1	`5bbf6a4d5a75…`

Additional Listing Data#

Finished product: Yes
Brand name base: Buspirone Hydrochloride
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
BUSPIRONE HYDROCHLORIDE	30 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
207LT9J9OC	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 5 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
866018	Internal RxNorm lookup
866083	Internal RxNorm lookup
866090	Internal RxNorm lookup
866094	Internal RxNorm lookup
866111	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
b08dd2e7-e808-4b51-b404-5009076b82eb	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
a9968269-ddf2-400e-9170-7376dcf3545a	Product name	1	20251215
2cf3c2e9-d566-c982-009a-188fe4f776b9	Product name	8	20200428
4a9096ce-7b98-89e5-5942-15f48c4f7abf	Product name	5	20190711

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
75834-270-60	Buspirone Hydrochloride	60 in 1 BOTTLE	TABLET	60		1

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
75834-270-60	EA - Each	75834-270	ba1038a8-d82c-4fcd-8abe-b851c545816b	1	2021-04-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
75834-270	BUSPIRONE HYDROCHLORIDE TABLET [NIVAGEN PHARMACEUTICALS INC.]	1	Current NDC, Legacy NDC, 1 package rows	20210227_b08dd2e7-e808-4b51-b404-5009076b82eb.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	Bryant Ranch Prepack	267d8897-90dd-4f8a-bbd8-8aa4e47c2905	2024-07-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209696 application number: ANDA209696
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	APNAR PHARMA LP	3c115eea-9dbc-4e2c-9d79-42e3388fde5a	2024-06-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209696 application number: ANDA209696
Buspirone Hydrochloride	BUSPIRONE HYDROCHLORIDE	Nivagen Pharmaceuticals Inc.	b08dd2e7-e808-4b51-b404-5009076b82eb	2021-02-25	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209696 application number: ANDA209696 ndc (product): 75834-270
BusPIRone Hydrochloride	BUSPIRONE HYDROCHLORIDE	Proficient Rx LP	03efd618-8ca3-43d0-bbeb-55e53b5308e8	2020-04-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209696 application number: ANDA209696
BusPIRone Hydrochloride	BUSPIRONE HYDROCHLORIDE	Aphena Pharma Solutions - Tennessee, LLC	e2c672b3-6130-4dd1-8066-0ce9451cb8c7	2019-06-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209696 application number: ANDA209696

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
207LT9J9OC	BUSPIRONE HYDROCHLORIDE	33386-08-2	BUSPIRONE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
866083	busPIRone HCl 10 MG Oral Tablet	PSN	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866018	busPIRone HCl 15 MG Oral Tablet	PSN	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866090	busPIRone HCl 30 MG Oral Tablet	PSN	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866094	busPIRone HCl 5 MG Oral Tablet	PSN	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866111	busPIRone HCl 7.5 MG Oral Tablet	PSN	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866083	buspirone hydrochloride 10 MG Oral Tablet	SCD	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866018	buspirone hydrochloride 15 MG Oral Tablet	SCD	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866090	buspirone hydrochloride 30 MG Oral Tablet	SCD	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866094	buspirone hydrochloride 5 MG Oral Tablet	SCD	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866111	buspirone hydrochloride 7.5 MG Oral Tablet	SCD	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866083	buspirone HCl 10 MG (buspirone 9.1 MG) Oral Tablet	SY	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866111	buspirone HCl 7.5 MG (buspirone 6.9 MG) Oral Tablet	SY	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866018	buspirone hydrochloride 15 MG (buspirone 13.7 MG) Oral Tablet	SY	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866090	buspirone hydrochloride 30 MG (buspirone 27.4 MG) Oral Tablet	SY	b08dd2e7-e808-4b51-b404-5009076b82eb	1
866094	buspirone hydrochloride 5 MG (buspirone 4.6 MG) Oral Tablet	SY	b08dd2e7-e808-4b51-b404-5009076b82eb	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
75834-270-60	75834027060	60 TABLET in 1 BOTTLE (75834-270-60)	60 tablet	2021-02-15	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Buspirone Hydrochloride Tablets, USP	Nivagen Pharmaceuticals Inc.	2021-02-25	HUMAN PRESCRIPTION DRUG LABEL	1